A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics
Yükleniyor...
Dosyalar
Tarih
2020
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Lippincott Williams & Wilkins
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Improvements in the medical management of heart failure have changed the course of the disease. However, mortality rates, hospitalization rates, and treatment costs are not at desired levels. Diuretics have been widely used in the treatment of congestion in heart failure patients. The following case reports represent a special patient group treated and followed by cardiology clinic. Treatment approach of each case report has been tailored on an individual basis depending on the clinical course and hospitalization rates of patients. Authors have highlighted and discussed the common aspects and future perspectives of their cases in which post-discharge intermittent empirical intravenous diuretic administration dramatically improved the clinical status and readmission number due to decompensated congestive heart failure. This is a relatively new and promising approach, which has been thought to cease the recycle of diuretic resistance and silent increase of fluid congestion in patients with congestive heart failure and frequent hospitalization. Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.
Açıklama
Anahtar Kelimeler
Diuretic Therapy, Furosemide, Heart Failure, Hospitalization, Intermittent
Kaynak
Cardiovascular Endocrinology & Metabolism
WoS Q Değeri
N/A
Scopus Q Değeri
Q2
Cilt
9
Sayı
2
Künye
Yetkin, E., Cuglan, B., Turhan, H., & Ozturk, S. (2020). A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics. CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 9(2), 60–63. https://doi.org/10.1097/XCE.0000000000000200
